Stephen K. Brannan, Chief Medical Officer at Karuna Therapeutics, Inc. (KRTX), sold 15,000 shares at $316.81 ($4.8M) on 2024-01-08, disclosed to the SEC on 2024-01-09.
Scheduled sale ($4.8M) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| KRTX | SELL | 2024-02-12 | $3.2M | — | Filing → |
| KRTX | SELL | 2023-12-12 | $4.0M | — | Filing → |
| KRTX | SELL | 2023-11-13 | $1.7M | — | Filing → |